Skip to main content
All lobbying filings

WALMART INC.

Lobbying for WALMART INC

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Arkansas · House · Senate · $1,600,000.00 expenses · posted Oct 20, 2025

Official filing document

 Bills named in this filing 5
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 3074
    Common Cents Act
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • S 2426
    Equitable Community Access to Pharmacist Services Act
  • HR 5166
    Financial Services and General Government Appropriations Act, 2026
 Lobbying activity 17
Labor Issues/Antitrust/Workplace

Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work

Veterans

Discussions regarding veteran and military spouse programs

Trade (domestic/foreign)

Discussions regarding trade enforcement actions and tariff proposals by the Administration

Manufacturing

Discussions regarding U.S. manufacturing commitment and supply chain policy

Food Industry (safety, labeling, etc.)

Discussions related to nutrition assistance programs Discussions related to farm bill priorities Discussions related to groceries, consumer pricing, food processing and manufacturing, organics, and food ingredients as well as efforts to reduce food waste

Taxation/Internal Revenue Code

Discussions related to corporate tax rate, tax credits and revenue measures, H.R.1, One Big Beautiful Bill Act (2025) Discussions regarding international taxation: OECD Pillar II Model rules Discussions regarding the Work Opportunity Tax Credit

Banking

Discussions on payment acceptance Discussions in support of the Credit Card Competition Act Discussions regarding the elimination of the penny, H.R. 3074, Common Cents Act

Law Enforcement/Crime/Criminal Justice

Discussions in support of the Combating Organized Retail Crime Act

Health Issues

Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to pharmacy and reimbursement

Budget/Appropriations

Discussions regarding H.R.5166, the Financial Services and General Government Appropriations Act, 2026

Immigration

Discussions related to modifications to the work visa program

Science/Technology

Discussions related to Artificial Intelligence(AI)

Energy/Nuclear

Discussions related to energy demand and renewables

Torts

Discussions related to Civil Litigation Transparency

Consumer Issues/Safety/Products

Discussions related to TSCA section 5 review process Discussions related to on-line marketplace compliance programs

Transportation

Discussions related to potential fees on non-US made or flagged shipping vessels Discussions related to Pier Pass Program Discussions regarding priorities for Surface Transportation Reauthorization

Aviation/Airlines/Airports

Matters related to Part 108 BVLOS Rule

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem